Brief: 2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share
11/03/2025 02:20
March 10 (Reuters) - 2Seventy Bio Inc TSVT.O: 2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BRISTOL MYERS SQUIBB 2SEVENTY BIO INC - DEAL VALUED AT $5.00 PER SHARE, ALL-CASH TRANSACTION 2SEVENTY BIO INC - TOTAL EQUITY VALUE OF APPROXIMATELY $286 MILLION 2SEVENTY BIO INC - DEAL REPRESENTS 88% PREMIUM TO CLOSING PRICE Source text: ID:nBw9fnF27a Further company coverage: TSVT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney